This episode of CRACKCast cover’s Rosen’s Chapter 07, Blood and Blood Components. A knowledge of blood and blood components is essential both for diagnosis and treatment.
Shownotes – PDF Link
[bg_faq_start]1) Describe the 3 categories of blood antigens
- The whole goal of blood typing is to match ABO type, Rh antibodies, and over 200 other antigens with a suitable donor to avoid immune and nonimmune transfusion reactions
- The 3 categories of blood antigens are: A, B, AB
* Group O has no a blood antigen type, because it is the absence of antigens - That being said, there is also the Rhesus (Rh) system which has over 50 antigens, of which the D antigen is the most important
- This becomes important in the woman who is A-, and is miscarrying….she should have no anti-D antibodies naturally. But she will have anti-B antibodies in the plasma….more on that in upcoming chapters!
2) Who is the universal donor and why?
- Blood type O:
- They have no antigens on their RBC’s and can give their blood to anyone without fear of ABO incompatibility
- The universal recipient is AB+
- Let’s think through this again: they have A and B antigens on their RBC’s, but they won’t have any antibodies in the plasma
- The + Rh status means that they have Rh D antigens, and no Rh D antibodies (can receive both RhD + or RhD- blood)
3) Define massive transfusion.
- Infusion of >10 units of blood in 24 hour period
4) List 5 physiologic complications of massive transfusion
- Complications
- hypothermia — > increased clotting time
- electrolyte abnormalities
- hypomagnesemia
- hypocalcemia (citrate binds calcium)
- hyper/hypo K+
- acidosis (from shock and/or excess citrate)
- coagulopathy
- thrombocytopenia
5) What are the indications for the administration of: pRBCs, FFP, platelets, and cryoprecipitate
[bg_faq_start]pRBCs – Packed Red Blood Cells
- goal is to improve oxygen delivery and improve intracellular oxygen consumption
- 1 unit = 450 ml = increases Hgb by ~10
- in pediatrics give 10 ml/kg
- need to infuse with NS only
- given over 60 mins to max 4 hrs
- TRICC trial suggests that in critical care setting the hgb threshold for transfusion is <70 (in general if not actively hemorrhaging)
- FOCUS trial for hip fractures support blood transfusion if Hgb <80
FFP – Fresh Frozen Plasma
- contains all the natural clotting factors
- can be spun down to various components depending on the indication
- 1 unit = 250 ml
- must be ABO compatible
- Indications
- massive transfusion in trauma
- coagulopathy of trauma
- hemorrhage in DIC or liver cirrhotics
- plasma exchange in TTP
- emergency reversal in warfarin – if you don’t have octaplex
- 10-30 ml/kg
- not indicated in non-urgent Vit. K antagonism or volume expansion
Platelets
- Rh- patients need Rh- platelets
- patients needing frequent transfusions may need leuko-reduced platelets
- indications
- platelet count <10 (very little bleeding risk until platelets drop below 5)
- Dose
- “six pack” – 6 units of platelets (raises platelets 40-60 points)
- Very few large studies to support specific transfusion recommendations
- General rules for platelet transfusion before procedures:
- LP : > 10
- central line placement: >20-30
- major surgery: > 50
- neuro Sx or retinal Sx: > 100
- patients with anemia are more prone to bleeding
- platelets are ineffective in immune-mediated thrombocytopenia
- ITP
- TTP
Cryoprecipitate – “Cryo”
- Contains:
- fibrinogen, fibronectin
- vWF
- factor VIII, XIII,
- Indications:
- bleeding with a low fibrinogen level
- dysfibrinogenemia
- bleeding in von Willebrand’s disease that in unresponsive to DDAVP and no Factor VIII around
- Think of cryoprecipitate as a filtered version of FFP (more rarely used) and now becoming obsolete due to advances in factor concentration technology…may be useful for patients who are deficient in fibrinogen.
- Contains:
6) List 6 complications of blood transfusions and their management
- Rosen’s breaks the complications associated with blood transfusions into:
- immune mediated adverse effects
- non-immune mediated adverse effects
Immune mediate adverse effects:
- Can be either acute or delayed
Acute:
- Intravascular hemolytic transfusion reaction
- MOST serious complication due to ABO incompatibility
- biochemically it can present with hemoglobinemia and hemoglobinuria
- but the patients usually have:
- fevers, chills, headache, N/V, joint and low back pain, chest restriction, pain at the site of infusion, feeling of impending doom
- Hypotension, DIC, fevers,
- Treatment
- STOP the infusion, change tubing, crystalloid fluids
- send samples to the lab
- but the patients usually have:
- biochemically it can present with hemoglobinemia and hemoglobinuria
- MOST serious complication due to ABO incompatibility
- Transfusion related acute lung injury (TRALI)
- leading cause of transfusion related mortality
- “new acute lung injury: bilateral pulmonary edema and hypoxemia” within 6 hrs of the transfusion
- presentation
- non-cardiogenic pulmonary edema, dyspnea, hypoxia
- bilateral chest infiltrates, fever
- treatment
- stop transfusion
- provide resp. support,
- very little benefit to diuretics
- usual recovery is 4 days
- leading cause of transfusion related mortality
- Allergic reactions
- range in severity from urticaria to anaphylaxis
- Treat:
- antihistamine, and anaphylaxis care PRN
- STOP the transfusion
- rarely full anaphylaxis can occur with IgA deficiency (use washed RBC’s)
- Febrile transfusion reaction
- most common and least serious reaction
- defined by a rise in patients temperature by at least 1 deg. C
- Treatment
- analgesics, antipyretics, antihistamines
Delayed:
- EXTRAvascular hemolytic transfusion reaction
- result from non-ABO mediated immune reaction
- extravascular hemolysis occurs days-weeks later
- fever, anemia, jaundice, oliguria
- result from non-ABO mediated immune reaction
- Transfusion associated graft vs. host disease
- RARE
- life threatening >90% mortality
- transfused lymphocytes proliferate and attack the recipient
- presentation
- 3-30 days post transfusion: fever, erythematous rash, diarrhea, elevated liver enzymes, pancytopenia,
- treatment:
- bone marrow transplant
- prevention
- most blood products are gamma irradiated to kill lymphocytes especially in patients who are immunodeficient (leukemias, lymphomas)
- RARE
Non-immune mediated adverse effects
- Can be either acute or chronic
Acute
- Transfusion Associated Circulatory Overload (TACO)
- high risk patients: chronic anemias who are already normovolemic and elderly
- treatment: infuse over 4 hrs, consider using diuretics
- Bacterial Contamination
- most commonly Yersinia enterocolitica
- rare 1:1 million units transfused
- platelets carry higher risk of infection (pooled from 6 people)
- symptoms
- during transfusion: rigors, vomiting, abdominal cramps, fever, shock, renal failure, DIC
- treatment
- stop the transfusion, obtain blood cultures, give broad-spectrum antibiotics
- most commonly Yersinia enterocolitica
Chronic
- Transmitted Viruses
- Hep C and HIV
- 1: 1-2 million
- Hep B:
- 1: 200 000
- CMV
- Rare – those with allogeneic stem cell or solid organ transplants are at higher risk
- these patients should receive CMV-neg. blood
- Rare – those with allogeneic stem cell or solid organ transplants are at higher risk
- Hep C and HIV
Wisecracks:
[bg_faq_start]1) What are the components of octaplex (Prothrombin Complex Concentrate – PCC)? When is it indicated?
- Octaplex is generically known as Prothrombin Complex Concentrates (PCC) and is usually a 3 or 4 component HUMAN blood product
- it contains:
- Factors II, VII, IX, X (1972 – what warfarin blocks) as well as Protein C and S.
- other names include: Beriplex and Kcentra
- It is used to reverse SEVERE bleeding in the warfarin anticoagulated patient and is dosed in units per KG (usually 50u/kg)
- Strict indications for warfarin anticoagulated patient:
- life threatening hemorrhage from anywhere
- any intracranial hemorrhage
- any spinal hemorrhage
- needed emergent surgery
- it usually works in about 1 hour
- the step wise approach for serious or life-threatening bleeding with any INR on a warfarinised patient is:
- hold the warfarin
- give 10 mg Vitamin K by IV infusion
- give PCC (may need approval from hematologist)
- the step wise approach for serious or life-threatening bleeding with any INR on a warfarinised patient is:
2) What is FEIBA?
- It stands for “factor eight inhibitor bypassing activity”
- it is an ACTIVATED form of prothrombin complex concentrate
- it’s used to treat serious bleeding in hemophilia A with inhibitors
- let’s stop there… any more specific indications should be discussed with your friendly hematologist!!
3) List the three types of plasma that are available from the blood bank?
- fresh frozen plasma
- cryoprecipitate
- cryo-poor plasma (depleted of vWF, Factors VIII, XIII, fibrinogen, fibronectin
4) What are the absolute and off-label uses for recombinant factor VII?
- Absolute:
- treat bleeding in patients with:
- hemophilia A or B with inhibitors for 8 or 9
- acquired hemophilia
- congenital factor VII deficiency
- off-label
- management of intractable bleeding in non-hemophiliac patients
- many examples:
- vWD, warfarin associated bleeding, coagulopathy of liver dysfunction, post-traumatic hemorrhage, etc.
- many examples:
- management of intractable bleeding in non-hemophiliac patients
- treat bleeding in patients with:
5) Which products are most likely to result in sepsis?
- Plasma – it is stored at room temperature
6) What is a hyperhemolytic crisis?
- It is essentially a hemolytic crisis, but this can occur in people with sickle cell disease and G6PD
7) Breaking down transfusion reactions another way: ACUTE vs DELAYED
- ACUTE reactions
- ABO incompatibility – ie. INTRAvascular hemolytic transfusion reaction
- TRALI
- TACO
- bacterial contamination
- allergic reaction
- febrile transfusion reaction
- DELAYED reactions – all of which are severe but we probably won’t see
- graft vs. host disease
- EXTRAvascular hemolytic transfusion reaction
- viral transmission:
- HepC,B, HIV, CMV
This post was copyedited and uploaded by Michael Bravo (@bravbro).
1.
Marx J. Rosen’s Emergency Medicine – Concepts and Clinical Practice. Mosby; 2015.